In a promising advance for cancer treatment, Northwestern University scientists have re-engineered the molecular structure of ...

Scientists uncover a molecular weakness that could transform prostate cancer therapy. An international team of researchers has identified a new weakness in prostate cancer cells that could enhance ...

A new drug combination cuts the risk of death in people with advanced prostate cancer by 40% over eight years, according to ...

The combination of Merck's Welireg and Eisai's Lenvima has not yet shown statistical significance in extending overall ...

Prior research on the potential role of cytokines found that IL-6 signaling can reprogram and alter T-cell immune responses ...

A groundbreaking study at Vanderbilt University Medical Center (VUMC) is changing the face of kidney cancer treatment.Doctors ...

A powerful new drug combo has yielded a major breakthrough for men battling an aggressive form of prostate cancer, ...

(Reuters) -The U.S. Food and Drug Administration has approved British drugmaker GSK's blood cancer drug, Blenrep, in one ...

Mayo Clinic researchers have discovered a key reason why certain breast cancers might not respond to an important new class ...

A newly developed antibody which restricts the growth of treatment-resistant breast cancers offers new hope for patients.

GSK raised its 2025 sales and earnings forecasts on Wednesday as its speciality HIV and cancer drugs posted double digit ...

Vivan Therapeutics is a pioneer in cancer treatment innovation through its novel approach to personalized medicine. By using ...